The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.
Organon's NEXPLANON receives U.S. FDA sNDA approval for extended duration of use up to five years, including data for use in ...
Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...
Organon (OGN) has received FDA approval to expand the label of its birth control implant Nexplanon from its current three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results